Skip to content
Clinical Trials – home
Research site

Ambulatory of specialized outpatient medical help in internal diseases and cardiology Individual practice Cardio Tonus EOOD

Bulgaria Druzhba II Bl 284 Ent А Fl 0 Ap М14 5, District Iskar, 1582 Sofia, Bulgaria

  • 4 trials recruiting
  • Cardiovascular disorder · Hypertension · Cardiac failure
  • Adult patients

About Specializations

Ambulatory of specialized outpatient medical help in internal diseases and cardiology Individual practice Cardio Tonus EOOD in Sofia, Bulgaria specialises in clinical trials of conditions such as Cardiovascular disorder, Hypertension, Cardiac failure, Hypertriglyceridaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

The medical center is at the forefront of cardiovascular research, focusing on innovative treatments for lipid disorders. The center's work in this field is pivotal in understanding and managing conditions that affect heart health.

  • Hyperlipidemia
  • Triglyceride Management
  • Cardiovascular Risk Reduction

By exploring novel therapeutic approaches, the center contributes significantly to reducing the burden of cardiovascular diseases globally.

Endocrinology and Metabolism

Specializing in endocrinology and metabolism, the center conducts cutting-edge research on metabolic disorders, particularly focusing on severe hypertriglyceridemia. This research is crucial for developing effective interventions for metabolic health.

  • Severe Hypertriglyceridemia
  • Metabolic Syndrome
  • Insulin Resistance

The center's efforts in this area aim to improve patient outcomes through targeted therapies and personalized medicine.

Clinical Pharmacology

The institution excels in clinical pharmacology, focusing on the development and evaluation of new pharmacological agents. This research is essential for advancing therapeutic options and ensuring drug safety and efficacy.

  • Drug Development
  • Pharmacokinetics
  • Therapeutic Drug Monitoring

Through rigorous clinical trials and research, the center plays a vital role in bringing innovative treatments to the market.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Druzhba II Bl 284 Ent А Fl 0 Ap М14 5, District Iskar1582 SofiaBulgaria
Recruiting now
4 trials
Conditions studied
7

More sites in SofiaBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

8 clinical trials

Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Cardiac failure

Recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Obesity

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Arteriosclerosis

Not recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Atorvastatin
  • Sponsor:Novartis Pharma AG
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.